Literature DB >> 15758162

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

Cristina Benito1, Woong-Ki Kim, Wong-Ki Kim, Iván Chavarría, Ceceila J Hillard, Ken Mackie, Rosa M Tolón, Kenneth Williams, Ken Williams, Julián Romero.   

Abstract

Recent evidence supports the notion that the endocannabinoid system may play a crucial role in neuroinflammation. We explored the changes that some elements of this system exhibit in a macaque model of encephalitis induced by simian immunodeficiency virus. Our results show that profound alterations in the distribution of specific components of the endocannabinoid system occur as a consequence of the viral infection of the brain. Specifically, expression of cannabinoid receptors of the CB2 subtype was induced in the brains of infected animals, mainly in perivascular macrophages, microglial nodules, and T-lymphocytes, most likely of the CD8 subtype. In addition, the endogenous cannabinoid-degrading enzyme fatty acid amide hydrolase was overexpressed in perivascular astrocytes as well as in astrocytic processes reaching cellular infiltrates. Finally, the pattern of CB1 receptor expression was not modified in the brains of infected animals compared with that in control animals. These results resemble previous data obtained in Alzheimer's disease human tissue samples and suggest that the endocannabinoid system may participate in the development of human immunodeficiency virus-induced encephalitis, because activation of CB2 receptors expressed by immune cells is likely to reduce their antiviral response and thus could favor the CNS entry of infected monocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758162      PMCID: PMC6725174          DOI: 10.1523/JNEUROSCI.3923-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.

Authors:  J M Derocq; O Jbilo; M Bouaboula; M Ségui; C Clère; P Casellas
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

Review 2.  Pathogenesis of simian immunodeficiency virus infection.

Authors:  L E Whetter; I C Ojukwu; F J Novembre; S Dewhurst
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

3.  HIV and HIV dementia.

Authors:  D L Kolson; F González-Scarano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  Antigen retrieval techniques: current perspectives.

Authors:  S R Shi; R J Cote; C R Taylor
Journal:  J Histochem Cytochem       Date:  2001-08       Impact factor: 2.479

Review 5.  The chimpanzee and other non-human-primate models in HIV-1 vaccine research.

Authors:  B M Nath; K E Schumann; J D Boyer
Journal:  Trends Microbiol       Date:  2000-09       Impact factor: 17.079

Review 6.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

7.  Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry.

Authors:  K Tsou; M I Nogueron; S Muthian; M C Sañudo-Pena; C J Hillard; D G Deutsch; J M Walker
Journal:  Neurosci Lett       Date:  1998-10-02       Impact factor: 3.046

Review 8.  Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.

Authors:  R G Pertwee
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

Review 9.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  61 in total

1.  Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.

Authors:  Brady K Atwood; James Wager-Miller; Christopher Haskins; Alex Straiker; Ken Mackie
Journal:  Mol Pharmacol       Date:  2011-11-07       Impact factor: 4.436

Review 2.  The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.

Authors:  Roger G Pertwee
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

3.  The endocannabinoid system and Alzheimer's disease.

Authors:  Cristina Benito; Estefanía Núñez; María Ruth Pazos; Rosa María Tolón; Julián Romero
Journal:  Mol Neurobiol       Date:  2007-09-05       Impact factor: 5.590

Review 4.  Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

Authors:  Guy A Cabral; LaToya Griffin-Thomas
Journal:  Expert Rev Mol Med       Date:  2009-01-20       Impact factor: 5.600

Review 5.  An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Curr Opin Anaesthesiol       Date:  2018-08       Impact factor: 2.706

Review 6.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Authors:  G A Cabral; L Griffin-Thomas
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-09       Impact factor: 2.895

7.  Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.

Authors:  Servio H Ramirez; János Haskó; Andrew Skuba; Shongshan Fan; Holly Dykstra; Ryan McCormick; Nancy Reichenbach; Istvan Krizbai; Anu Mahadevan; Ming Zhang; Ronald Tuma; Young-Jin Son; Yuri Persidsky
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

8.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

9.  Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Paul A Meozzi; Lester Myers; Alex Perchuk; Zoila Mora; Patricia A Tagliaferro; Eileen Gardner; Alicia Brusco; B Emmanuel Akinshola; Qing-Rong Liu; Sanika S Chirwa; Bruce Hope; Javier Lujilde; Toshiya Inada; Shinya Iwasaki; David Macharia; Lindsey Teasenfitz; Tadao Arinami; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Authors:  Marylou V Solbrig; Neal Hermanowicz
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.